Literature DB >> 3977197

Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families.

W M Law, H Heath.   

Abstract

Familial benign hypercalcemia (hypocalciuric hypercalcemia) was diagnosed in 125 members of 21 families. The syndrome was generally characterized by autosomal dominant inheritance of symptomless, nonprogressive hypercalcemia with normal serum immunoreactive parathyroid hormone concentrations, parathyroid glands that had normal gross and histologic features, relatively low urinary excretion of calcium, and failure to achieve normocalcemia after subtotal parathyroidectomy. Affected persons had normal longevity and no discernible increase in other medical problems except gallstones. The parathyroid glands were not seen using high-resolution ultrasonography. Plasma calcitonin and calcitriol levels were normal or low. Skeletal mass was normal as assessed by photon absorptiometry of the radius and lumbar spine, and fractures were not more frequent. Familial benign hypercalcemia or hypocalciuric hypercalcemia is a distinctive heritable syndrome that should always be considered in the differential diagnosis of asymptomatic hypercalcemia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977197     DOI: 10.7326/0003-4819-102-4-511

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  32 in total

Review 1.  Familial hypocalciuric hypercalcemia.

Authors:  D A Heath
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

3.  In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia.

Authors:  M Bai; S H Pearce; O Kifor; S Trivedi; U G Stauffer; R V Thakker; E M Brown; B Steinmann
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades.

Authors:  Marcio L Griebeler; Ann E Kearns; Euijung Ryu; Prabin Thapa; Matthew A Hathcock; L Joseph Melton; Robert A Wermers
Journal:  J Clin Endocrinol Metab       Date:  2016-01-11       Impact factor: 5.958

5.  24-hour urinary calcium in primary hyperparathyroidism.

Authors:  Carrie E Black; Richard L Berg; Andrew C Urquhart
Journal:  Clin Med Res       Date:  2013-12

6.  Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M Bai; N Janicic; S Trivedi; S J Quinn; D E Cole; E M Brown; G N Hendy
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 7.  Endocrine control and disturbances of calcium and phosphate metabolism in children.

Authors:  K Kruse
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

8.  A case report of familial benign hypocalciuric hypercalcemia: a mutation in the calcium-sensing receptor gene.

Authors:  Seong Ill Woo; Hyunju Song; Kyung Eun Song; Dae Jung Kim; Kwan Woo Lee; Se Joong Kim; Yoon-Sok Chung
Journal:  Yonsei Med J       Date:  2006-04-30       Impact factor: 2.759

9.  Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  N Janicic; Z Pausova; D E Cole; G N Hendy
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

Review 10.  Physiology and pathophysiology of the calcium-sensing receptor in the kidney.

Authors:  Daniela Riccardi; Edward M Brown
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.